Aid-Tec recently introduced a unique bandage line that contains a breakable capsule that when broken releases a dose of a multi-compound therapeutic substance onto the bandage.
Infirst Healthcare on Wednesday announced the introduction of three new chocolate-flavored cough-cold items called Dr. Cocoa.
Arctic Ease, a company that makes cold and compression therapy products, announced Tuesday that it had launched its small joints wrap.
Upsher-Smith Labs on Monday announced the launch of topiramate extended-release capsules, an authorized generic version of Qudexy XR (topiramate) extended-release capsules.
Sandoz on Monday announced the introduction of tobramycin inhalation solution, USP into the U.S. market. The drug is an authorized generic version of Tobi from Novartis.
Anacor Pharmaceuticals announced that the Food and Drug Administration has approved the company's new drug application for Kerydin (tavaborole) topical solution, 5% — an antifungal approved for the topical treatment of onychomycosis of the toenails.
A wave of new drug introductions and healthcare policy changes has had a significant impact on women’s health care over the past year.
Greenstone, a U.S.-based subsidiary of Pfizer, announced the introduction of doxazosin mesylate tablets.
Purdue Pharma on Tuesday announced that the Food and Drug Administration has granted priority review designation for the company's once-daily, single-entity hydrocodone bitartrate tablet.
Mylan announced the launch of telmisartan tablets USP, which is used to treat hypertension.